Literature DB >> 17121821

The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation.

Claire Sunyach1, Moustapha Alfa Cisse, Cristine Alves da Costa, Bruno Vincent, Frédéric Checler.   

Abstract

The cellular prion protein (PrP(c)) undergoes various endopro-teolytic attacks within its N-terminal domain, leading to the production of C-terminal fragments (C) tethered to the plasma membrane and soluble N-terminal peptides (N). One of these cleavages occurs at position 110/111, thereby generating C1 and N1 products. We have reported that disintegrins ADAM-10, -9, and -17 participate either directly or indirectly to this proteolytic event. An alternative proteolytic event taking place around residue 90 yields C2 and N2 fragments. The putative function of these proteolytic fragments remained to be established. We have set up two novel human embryonic kidney 293 cell lines stably overexpressing either C1 or C2. We show that C1 potentiates staurosporine-induced caspase-3 activation through a p53-dependent mechanism. Thus, C1 positively controls p53 transcription and mRNA levels and increases p53-like immunoreactivity and activity. C1-induced caspase-3 activation remained unaffected by the blockade of endocytosis in HEK 293 cells and was abolished in p53-deficient fibroblasts. Conversely, overexpression of the C2 fragment did not significantly sensitize HEK 293 cells to apoptotic stimuli and did not modify p53 mRNA levels or activity. Therefore, the nature of the proteolytic cleavage taking place on PrP(c) yielded C-terminal catabolites with distinct function and could be seen as a switch mechanism controlling the function of the PrP(c) in cell survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121821     DOI: 10.1074/jbc.M609663200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

2.  Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.

Authors:  Yuzuru Taguchi; Lindsay A Hohsfield; Jason R Hollister; Gerald S Baron
Journal:  Chembiochem       Date:  2013-08-13       Impact factor: 3.164

3.  Axonal prion protein is required for peripheral myelin maintenance.

Authors:  Juliane Bremer; Frank Baumann; Cinzia Tiberi; Carsten Wessig; Heike Fischer; Petra Schwarz; Andrew D Steele; Klaus V Toyka; Klaus-Armin Nave; Joachim Weis; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2010-01-24       Impact factor: 24.884

4.  The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Charlotte Druon; Sabine Scarzello; Frédéric Checler
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  The P's and Q's of cellular PrP-Aβ interactions.

Authors:  David Westaway; Jack H Jhamandas
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

6.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

7.  Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein.

Authors:  Andrew R Castle; Nathalie Daude; Sabine Gilch; David Westaway
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

8.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

9.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

10.  Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Authors:  Victoria Lewis; Vanessa A Johanssen; Peter J Crouch; Genevieve M Klug; Nigel M Hooper; Steven J Collins
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.